209 related articles for article (PubMed ID: 26267657)
1. Characterization of the MUC1-C Cytoplasmic Domain as a Cancer Target.
Raina D; Agarwal P; Lee J; Bharti A; McKnight CJ; Sharma P; Kharbanda S; Kufe D
PLoS One; 2015; 10(8):e0135156. PubMed ID: 26267657
[TBL] [Abstract][Full Text] [Related]
2. Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells.
Raina D; Ahmad R; Rajabi H; Panchamoorthy G; Kharbanda S; Kufe D
Int J Oncol; 2012 May; 40(5):1643-9. PubMed ID: 22200620
[TBL] [Abstract][Full Text] [Related]
3. MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells.
Kosugi M; Ahmad R; Alam M; Uchida Y; Kufe D
PLoS One; 2011; 6(11):e28234. PubMed ID: 22140559
[TBL] [Abstract][Full Text] [Related]
4. The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function.
Ahmad R; Alam M; Rajabi H; Kufe D
J Biol Chem; 2012 Jun; 287(25):20866-75. PubMed ID: 22544745
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells.
Uchida Y; Raina D; Kharbanda S; Kufe D
Cancer Biol Ther; 2013 Feb; 14(2):127-34. PubMed ID: 23114713
[TBL] [Abstract][Full Text] [Related]
6. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62.
Leng Y; Cao C; Ren J; Huang L; Chen D; Ito M; Kufe D
J Biol Chem; 2007 Jul; 282(27):19321-30. PubMed ID: 17500061
[TBL] [Abstract][Full Text] [Related]
7. Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
Raina D; Ahmad R; Joshi MD; Yin L; Wu Z; Kawano T; Vasir B; Avigan D; Kharbanda S; Kufe D
Cancer Res; 2009 Jun; 69(12):5133-41. PubMed ID: 19491255
[TBL] [Abstract][Full Text] [Related]
8. Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.
Raina D; Kosugi M; Ahmad R; Panchamoorthy G; Rajabi H; Alam M; Shimamura T; Shapiro GI; Supko J; Kharbanda S; Kufe D
Mol Cancer Ther; 2011 May; 10(5):806-16. PubMed ID: 21421804
[TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.
Panchamoorthy G; Rehan H; Kharbanda A; Ahmad R; Kufe D
Hybridoma (Larchmt); 2011 Dec; 30(6):531-5. PubMed ID: 22149278
[TBL] [Abstract][Full Text] [Related]
10. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90.
Ren J; Bharti A; Raina D; Chen W; Ahmad R; Kufe D
Oncogene; 2006 Jan; 25(1):20-31. PubMed ID: 16158055
[TBL] [Abstract][Full Text] [Related]
11. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
[TBL] [Abstract][Full Text] [Related]
12. Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion.
Bernier AJ; Zhang J; Lillehoj E; Shaw AR; Gunasekara N; Hugh JC
Mol Cancer; 2011 Jul; 10():93. PubMed ID: 21798038
[TBL] [Abstract][Full Text] [Related]
13. Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.
Kharbanda A; Rajabi H; Jin C; Tchaicha J; Kikuchi E; Wong KK; Kufe D
Clin Cancer Res; 2014 Nov; 20(21):5423-34. PubMed ID: 25189483
[TBL] [Abstract][Full Text] [Related]
14. Interaction of human MUC1 and beta-catenin is regulated by Lck and ZAP-70 in activated Jurkat T cells.
Li Q; Ren J; Kufe D
Biochem Biophys Res Commun; 2004 Mar; 315(2):471-6. PubMed ID: 14766232
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the human MUC1 oncoprotein.
Duraisamy S; Kufe T; Ramasamy S; Kufe D
Int J Oncol; 2007 Sep; 31(3):671-7. PubMed ID: 17671696
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation.
Hasegawa M; Sinha RK; Kumar M; Alam M; Yin L; Raina D; Kharbanda A; Panchamoorthy G; Gupta D; Singh H; Kharbanda S; Kufe D
Clin Cancer Res; 2015 May; 21(10):2338-47. PubMed ID: 25712682
[TBL] [Abstract][Full Text] [Related]
17. Mucin 1 C-terminal subunit oncoprotein is a target for small-molecule inhibitors.
Zhou Y; Rajabi H; Kufe D
Mol Pharmacol; 2011 May; 79(5):886-93. PubMed ID: 21346142
[TBL] [Abstract][Full Text] [Related]
18. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop.
Ramasamy S; Duraisamy S; Barbashov S; Kawano T; Kharbanda S; Kufe D
Mol Cell; 2007 Sep; 27(6):992-1004. PubMed ID: 17889671
[TBL] [Abstract][Full Text] [Related]
19. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
[TBL] [Abstract][Full Text] [Related]
20. MUC1-C activates BMI1 in human cancer cells.
Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
